Abstract
Rationale
Recent studies have investigated d-amphetamine as a potential agonist medication for cocaine dependence. In rats, a 14-day continuous infusion of d-amphetamine via osmotic mini-pump has been shown to decrease cocaine-reinforced responding under a progressive ratio (PR) schedule of reinforcement.
Objectives
This study was designed to assess the influences of the d-amphetamine treatment dose and self-administered cocaine dose on the magnitude of this effect.
Materials and methods
Experiment 1: rats were trained to self-administer 1.5 mg/kg/inj cocaine under a PR schedule, then implanted with d-amphetamine mini-pumps for 14 days (days 1–7, 5 mg/kg/day; days 8–14, 7.5 mg/kg/day). Breakpoints were evaluated throughout the treatment period and 14 days post-treatment. Experiment 2: rats were trained to self-administer cocaine under a PR schedule and initial dose–response curves were determined before implantation of d-amphetamine mini-pumps. During the 14-day d-amphetamine (5 mg/kg/day) treatment period, rats self-administered one of four cocaine doses (0.19, 0.38, 0.75, or 1.5 mg/kg/inj). A post-treatment PR dose–response curve and responding under a fixed ratio 1 (FR1) schedule were evaluated after mini-pump removal.
Results
Experiment 1: breakpoints for 1.5 mg/kg/inj cocaine were unchanged by the increasing dose of d-amphetamine. Experiment 2: the PR dose–response curve was shifted downward after the treatment period in rats that had self-administered 0.19 and 0.38 mg/kg/inj cocaine. In contrast, rats in the 0.75 and 1.5 mg/kg/inj groups demonstrated increased rates of cocaine intake under an FR1 schedule after the treatment period.
Conclusions
These data suggest that continuous d-amphetamine treatment attenuates the reinforcing effects of cocaine.
Similar content being viewed by others
References
Barrett AC, Miller JR, Dohrmann JM, Caine SB (2004) Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats. Neuropharmacology 47(Suppl 1):256–273
Bonate PL, Swann A, Silverman PB (1997) Context-dependent cross-sensitization between cocaine and amphetamine. Life Sci 60:L1–L7
Brebner K, Phelan R, Roberts DC (2000) Effect of baclofen on cocaine self-administration in rats reinforced under fixed-ratio 1 and progressive-ratio schedules. Psychopharmacology (Berl) 148:314–321
Caplehorn JR, Bell J, Kleinbaum DG, Gebski VJ (1993) Methadone dose and heroin use during maintenance treatment. Addiction 88:119–124
Chiodo KA, Lack CM, Roberts DC (2008) Cocaine self-administration reinforced on a progressive ratio schedule decreases with continuous d-amphetamine treatment in rats. Psychopharmacology (Berl) 200:465–473
Cryan JF, Hoyer D, Markou A (2003) Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents. Biol Psychiatry 54:49–58
Des Jarlais DC (1995) Harm reduction—a framework for incorporating science into drug policy. Am J Public Health 85:10–12
Dole VP, Nyswander ME, Kreek MJ (1966) Narcotic blockade. Arch Intern Med 118:304–309
Eison MS, Eison AS, Iversen SD (1983) Two routes of continuous amphetamine administration induce different behavioral and neurochemical effects in the rat. Neurosci Lett 39:313–319
Ellison G, Morris W (1981) Opposed stages of continuous amphetamine administration: parallel alterations in motor stereotypies and in vivo spiroperidol accumulation. Eur J Pharmacol 74:207–214
Emmett-Oglesby MW, Lane JD (1992) Tolerance to the reinforcing effects of cocaine. Behav Pharmacol 3:193–200
Ferrario CR, Robinson TE (2007) Amphetamine pretreatment accelerates the subsequent escalation of cocaine self-administration behavior. Eur Neuropsychopharmacol 17:352–357
Fiellin DA, Friedland GH, Gourevitch MN (2006) Opioid dependence: rationale for and efficacy of existing and new treatments. Clin Infect Dis 43(Suppl 4):S173–S177
Fiore MC (2000) US public health service clinical practice guideline: treating tobacco use and dependence. Respir Care 45:1200–1262
Fleming PM, Roberts D (1994) Is the prescription of amphetamine justified as a harm reduction measure? J R Soc Health 114:127–131
Grabowski J, Rhoades H, Schmitz J, Stotts A, Daruzska LA, Creson D, Moeller FG (2001) Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial. J Clin Psychopharmacol 21:522–526
Grabowski J, Rhoades H, Stotts A, Cowan K, Kopecky C, Dougherty A, Moeller FG, Hassan S, Schmitz J (2004a) Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials. Neuropsychopharmacology 29:969–981
Grabowski J, Shearer J, Merrill J, Negus SS (2004b) Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict Behav 29:1439–1464
Hammer RP Jr, Egilmez Y, Emmett-Oglesby MW (1997) Neural mechanisms of tolerance to the effects of cocaine. Behav Brain Res 84:225–239
Horger BA, Giles MK, Schenk S (1992) Preexposure to amphetamine and nicotine predisposes rats to self-administer a low dose of cocaine. Psychopharmacology (Berl) 107:271–276
Hursh SR (1991) Behavioral economics of drug self-administration and drug abuse policy. J Exp Anal Behav 56:377–393
Hursh SR, Galuska CM, Winger G, Woods JH (2005) The economics of drug abuse: a quantitative assessment of drug demand. Mol Interv 5:20–28
Kokkinidis L (1984) Effects of chronic intermittent and continuous amphetamine administration on acoustic startle. Pharmacol Biochem Behav 20:367–371
Kosten T, Owens SM (2005) Immunotherapy for the treatment of drug abuse. Pharmacol Ther 108:76–85
Kreek MJ (2000) Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Ann N Y Acad Sci 909:186–216
Kreek MJ, Vocci FJ (2002) History and current status of opioid maintenance treatments: blending conference session. J Subst Abuse Treat 23:93–105
Lett BT (1989) Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology (Berl) 98:357–362
Li SM, Campbell BL, Katz JL (2006) Interactions of cocaine with dopamine uptake inhibitors or dopamine releasers in rats discriminating cocaine. J Pharmacol Exp Ther 317:1088–1096
Lynch WJ, Heaser WA, Carroll ME (1998) Effects of amphetamine, butorphanol, and morphine pretreatment on the maintenance and reinstatement of cocaine-reinforced responding. Exp Clin Psychopharmacol 6:255–263
Martin-Iverson MT, Lodge BA (1991) Effects of chronic treatment of rats with "designer" amphetamines on brain regional monoamines. Can J Physiol Pharmacol 69:1825–1832
McLellan AT, Alterman AI (1991) Patient treatment matching: a conceptual and methodological review with suggestions for future research. NIDA Res Monogr 106:114–135
Mendrek A, Blaha CD, Phillips AG (1998) Pre-exposure of rats to amphetamine sensitizes self-administration of this drug under a progressive ratio schedule. Psychopharmacology (Berl) 135:416–422
Montoya ID, Vocci F (2008) Novel medications to treat addictive disorders. Curr Psychiatry Rep 10:392–398
Negus SS (2003) Rapid assessment of choice between cocaine and food in rhesus monkeys: effects of environmental manipulations and treatment with d-amphetamine and flupenthixol. Neuropsychopharmacology 28:919–931
Negus SS, Mello NK (2003a) Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a progressive-ratio schedule in rhesus monkeys. Psychopharmacology (Berl) 167:324–332
Negus SS, Mello NK (2003b) Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus monkeys. Drug Alcohol Depend 70:39–52
Nelson LR, Ellison G (1978) Enhanced stereotypies after repeated injections but not continuous amphetamines. Neuropharmacology 17:1081–1084
Nielsen EB (1981) Rapid decline of stereotyped behavior in rats during constant one week administration of amphetamine via implanted ALZET osmotic minipumps. Pharmacol Biochem Behav 15:161–165
Oleson EB, Roberts DC (2009) Behavioral economic assessment of price and cocaine consumption following self-administration histories that produce escalation of either final ratios or intake. Neuropsychopharmacology 34:796–804
Orson FM, Kinsey BM, Singh RA, Wu Y, Gardner T, Kosten TR (2008) Substance abuse vaccines. Ann N Y Acad Sci 1141:257–269
Peltier RL, Li DH, Lytle D, Taylor CM, Emmett-Oglesby MW (1996) Chronic d-amphetamine or methamphetamine produces cross-tolerance to the discriminative and reinforcing stimulus effects of cocaine. J Pharmacol Exp Ther 277:212–218
Richardson NR, Roberts DC (1991) Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the rat. Life Sci 49:833–840
Richardson NR, Roberts DC (1996) Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66:1–11
Roberts DCS, Goeders NE (1989) Drug self-administration: experimental methods and determinants. In: Boulton AA, Baker GB, Greenshaw AJ (eds) Neuromethods: psychopharmacology, vol 13. Humana, Clifton, pp 349–398
Roberts DC, Bennett SA, Vickers GJ (1989) The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats. Psychopharmacology (Berl) 98:408–411
Roberts DC, Andrews MM, Vickers GJ (1996) Baclofen attenuates the reinforcing effects of cocaine in rats. Neuropsychopharmacology 15:417–423
Robinson TE, Camp DM (1987) Long-lasting effects of escalating doses of d-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion. Pharmacol Biochem Behav 26:821–827
Rothman RB, Baumann MH, Prisinzano TE, Newman AH (2008a) Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction. Biochem Pharmacol 75:2–16
Rothman RB, Blough BE, Baumann MH (2008b) Dopamine/serotonin releasers as medications for stimulant addictions. Prog Brain Res 172:385–406
Rush CR, Stoops WW, Hays LR (2009) Cocaine effects during d-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy. Drug Alcohol Depend 99:261–271
Ryan LJ, Linder JC, Martone ME, Groves PM (1990) Histological and ultrastructural evidence that d-amphetamine causes degeneration in neostriatum and frontal cortex of rats. Brain Res 518:67–77
Schenk S, Partridge B (1999) Cocaine-seeking produced by experimenter-administered drug injections: dose–effect relationships in rats. Psychopharmacology (Berl) 147:285–290
Schenk S, Snow S, Horger BA (1991) Pre-exposure to amphetamine but not nicotine sensitizes rats to the motor activating effect of cocaine. Psychopharmacology (Berl) 103:62–66
Shearer J (2008) The principles of agonist pharmacotherapy for psychostimulant dependence. Drug Alcohol Rev 27:301–308
Shearer J, Wodak A, van Beek I, Mattick RP, Lewis J (2003) Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence. Addiction 98:1137–1141
Shippenberg TS, Heidbreder C (1995) Sensitization to the conditioned rewarding effects of cocaine: pharmacological and temporal characteristics. J Pharmacol Exp Ther 273:808–815
Shuster L, Yu G, Bates A (1977) Sensitization to cocaine stimulation in mice. Psychopharmacology (Berl) 52:185–190
Stead LF, Perera R, Bullen C, Mant D, Lancaster T (2008) Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev CD000146
Theeuwes F, Yum SI (1976) Principles of the design and operation of generic osmotic pumps for the delivery of semisolid or liquid drug formulations. Ann Biomed Eng 4:343–353
Trafton JA, Minkel J, Humphreys K (2006) Determining effective methadone doses for individual opioid-dependent patients. PLoS Med 3:e80
Vocci F, Ling W (2005) Medications development: successes and challenges. Pharmacol Ther 108:94–108
Author information
Authors and Affiliations
Corresponding author
Additional information
Funding for this study was provided by Grants R01DA14030 and P50DA06634-14.
Rights and permissions
About this article
Cite this article
Chiodo, K.A., Roberts, D.C.S. Decreased reinforcing effects of cocaine following 2 weeks of continuous d-amphetamine treatment in rats. Psychopharmacology 206, 447–456 (2009). https://doi.org/10.1007/s00213-009-1622-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-009-1622-4